Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Acquisition positions Servier as a leader in pediatric low-grade glioma and expands…
Servier’s Voranigo (vorasidenib) Receives Prix Galien Awards Across Multiple Regions
Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and…
